SCHEMBL31362647

SCHEMBL31362647

CCOC(=O)CC(N[S+]([O-])C(C)(C)C)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 2/20 0.41
KCNA5 P22460 3/20 0.38
ALDH1A1 P00352 3/20 0.36
CYP1A2 P05177 1/20 0.36
PPID Q08752 1/20 0.36
CYP2C19 P33261 1/20 0.36
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
CASP1 P29466 1/20 0.34
NOS2 P35228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18640937 1.00 SMN1; SMN2 (0.44) SMN1; SMN2MEN1GAAKMT2ALMNA
SCHEMBL18640955 0.84 CYP1A2 (0.40) SMN1; SMN2MEN1GAAKMT2ALMNA
SCHEMBL29488888 0.84 FPR2 (0.33) GAAALDH1A1KDM4EHPGD
SCHEMBL20142638 0.83 ALDH1A1 (0.46) SMN1; SMN2MEN1KMT2AALDH1A1CYP1A2
SCHEMBL25235485 0.82 KCNB1 (0.34) LMNAALDH1A1CYP1A2PPIDCYP2C19
SCHEMBL4196483 0.82 CXCR1 (0.35) MEN1GAAKMT2ALMNACYP1A2
SCHEMBL30671308 0.82 MAPT (0.38) SMN1; SMN2MEN1GAAKMT2ALMNA
SCHEMBL22763608 0.80 SMN1; SMN2 (0.52) SMN1; SMN2MEN1GAAKMT2ALMNA
SCHEMBL18640966 0.80 PPID (0.39) MEN1GAAKMT2ALMNAKCNA5
SCHEMBL29214486 0.80 SMN1; SMN2 (0.47) SMN1; SMN2MEN1GAAKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025122956-A1 COMBINATION THERAPY VIVACE THERAPEUTICS, INC. (US) 2025-06-12 WO disclosed
WO-2025034563-A1 COMPOUNDS AND METHODS FOR TREATING CANCER VIVACE THERAPEUTICS, INC. (US) 2025-02-13 WO disclosed